| Literature DB >> 22848599 |
Wissam El-Hage1, Julie Léger, Aude Delcuze, Bruno Giraudeau, Franck Perrotin.
Abstract
BACKGROUND: The aim of the study was to characterize the maternal dimensions of anxiety, depression and prenatal attachment in women undergoing an amniocentesis. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22848599 PMCID: PMC3404955 DOI: 10.1371/journal.pone.0041777
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Maternal characteristics of the amniocentesis group “Amnio” (n = 222) and controls (n = 120).
| Amnio | Control | p-value | |
| Age at baseline | 34.9±5.1 | 28.2±5.0 | <0.001 |
| Indication of amniocentesis | |||
| High maternal age | 79 (36.6) | – | – |
| High serum marker | 148 (66.7) | – | – |
| Thick nape | 5 (2.3) | – | – |
| Cohabitation | 206 (93.2) | 104 (96.3) | 0.260 |
| Geographical origin | |||
| France | 205 (92.8) | 94 (87.0) | 0.088 |
| Europe | 5 (2.2) | 4 (3.7) | |
| Africa | 7 (3.2) | 10 (9.3) | |
| Asia | 2 (0.9) | 0 | |
| America | 2 (0.9) | 0 | |
| Professionally active | 188 (85.1) | 68 (63.0) | <0.001 |
| Number of years of studies | 14.9±2.7 | 14.1±2.6 | 0.009 |
| Tiring working conditions | 78 (35.3) | 32 (29.6) | 0.306 |
| Precarious housing | 5 (2.3) | 0 | 0.175 |
| Parent's death during childhood | 11 (5.1) | 8 (7.3) | 0.427 |
| Child abuse during childhood | 18 (8.4) | 2 (1.9) | 0.021 |
| Eating disorders during adolescence | 17 (7.9) | 7 (6.5) | 0.637 |
| Depression or anxiety during adolescence | 19 (8.9) | 3 (2.8) | 0.041 |
| Conjugal violence | 9 (4.2) | 1 (0.9) | 0.174 |
| Primiparous | 73 (33.0) | 48 (44.4) | 0.044 |
| Age at first child's birth | 28.5±5.4 | 24.8±4.2 | <0.001 |
| Gravidity | |||
| 0 | 8 (3.6) | 4 (3.7) | 0.012 |
| 1 | 54 (24.4) | 36 (33.3) | |
| 2 | 62 (28.1) | 35 (32.4) | |
| 3 | 52 (22.6) | 21 (19.5) | |
| 4 and over | 47 (21.3) | 12 (11.1) | |
| History of abortion or termination | 67 (30.3) | 30 (27.8) | 0.635 |
| History of amniocentesis | 29 (13.1) | 3 (2.8) | 0.003 |
| Infertility | 13 (5.9) | 3 (2.8) | 0.219 |
| Tobacco use before pregnancy | 70 (31.8) | 42 (38.9) | 0.204 |
| Tobacco use during pregnancy | 32 (14.6) | 22 (20.4) | 0.181 |
| Alcohol use before pregnancy | 90 (40.9) | 15 (13.9) | <0.001 |
| Alcohol use during pregnancy | 20 (9.1) | 1 (0.9) | 0.005 |
| Use of substitution products | 1 (0.5) | 1 (0.9) | 0.551 |
| Medications use during pregnancy | 43 (19.7) | 14 (13.0) | 0.130 |
| Type of medications | |||
| Psychotropic drugs | 6 (14.0) | 0 | 0.320 |
| Others | 39 (86.0) | 14 (100) |
Data are reported as mean ± standard deviation or n (%).
Fisher’s exact test.
Cochran-Armitage test for trend.
Characteristics of the partners of the participants from the amniocentesis group “Amnio” (n = 222) and the controls (n = 120).
| Amnio | Control | p-value | |
| Geographical origin | |||
| France | 191 (88.4) | 95 (88.8) | 0.866F |
| Europe | 9 (4.1) | 3 (2.8) | |
| Africa | 14 (6.5) | 9 (8.4) | |
| Asia | 1 (0.5) | 0 | |
| America | 1 (0.5) | 0 | |
| Professional activity | 210 (97.2) | 98 (91.6) | 0.045F |
| Number of years of studies | 14.4±2.9 | 13.5±3.2 | 0.015 |
| Tobacco consumption before pregnancy | 69 (32.1) | 52 (48.6) | 0.004 |
| Alcohol consumption before pregnancy | 120 (55.8) | 39 (36.5) | 0.001 |
| Drug consumption before pregnancy | 3 (1.4) | 3 (2.8) | 0.403 |
Data are reported as mean ± standard deviation or n (%). FFisher's exact test.
Figure 1Maternal state anxiety and depressive symptoms course during the pregnancy up to 40–45 days post natal.
Solid line is for control group, dotted line is for “routine amniocentesis” group and long-dashed line is for “Indicated amniocentesis” group.
Between-group differences in state-anxiety scores (STAI).
| Effect | Estimate | SE | p-value |
| Intercept | 38.24 | 1.41 | <0.001 |
| V2 | 0.22 | 1.26 | 0.860 |
| V4 | −0.84 | 1.48 | 0.571 |
| Propensity score | 2.65 | 2.39 | 0.268 |
| Routine amniocentesis | 1.83 | 2.23 | 0.413 |
| Indicated amniocentesis | 5.43 | 1.71 | 0.002 |
| V2 | −1.38 | 2.34 | 0.556 |
| V2 | −4.57 | 1.73 | 0.009 |
| V4 | −3.04 | 2.37 | 0.200 |
| V4 | −6.87 | 1.93 | <0.001 |
SE: Standard error; V1: Visit 1; V2: Visit 2; V4: Visit 4.
Between-group differences in depression scores (EPDS).
| Effect | Estimate | SE | p-value |
| Intercept | 6.34 | 0.66 | <0.001 |
| V2 | −0.003 | 0.58 | 0.996 |
| V4 | 0.40 | 0.71 | 0.573 |
| Propensity score | −0.09 | 1.11 | 0.937 |
| Routine amniocentesis | 1.40 | 1.04 | 0.180 |
| Indicated amniocentesis | 3.96 | 0.80 | <0.001 |
| V2 | −0.77 | 1.06 | 0.470 |
| V2 | −3.88 | 0.79 | <0.001 |
| V4 | −1.20 | 1.14 | 0.292 |
| V4 | −4.63 | 0.93 | <0.001 |
SE: Standard error; V1: Visit 1; V2: Visit 2; V4: Visit 4.
Antenatal maternal representations of attachment by group.
| Maternal representations | Amniocentesis | Controls | Total | |
| Routine | Indicated | |||
| Integrated-balanceddirected on child | 30 (63.8) | 80 (69.6) | 58 (84.1) | 168 |
| Integrated-balanced directedon oneself | 17 (36.2) | 33 (28.7) | 11 (15.9) | 61 |
| Limited-disengaged with fear | 0 (0) | 2 (1.7) | 0 (0) | 2 |
| Total | 47 | 115 | 69 | 231 |
Data are reported as n (%) or n.
Figure 2Clinical trial profile of the study.
Study plan.
| Visit 1 | Visit 2 | Visit 3 | Visit 4 | |
| 16–18 weeks of gestation | 20–24 weeks of gestation | 30–34 weeks of gestation | 30–45 dayspost-natal | |
| Socio-demographics | X | |||
| Addiction habits | X | X | X | |
| Life stress events, CAPS | X | |||
| Anxiety symptoms, STAI | X | X | X | |
| Depression symptoms, EPDS | X | X | X | |
| Dissociation symptoms, DES | X | X | X | |
| Maternal representations, IRMAG | X | |||
| Obstetrical data | X | |||
| Post-traumatic symptoms, PPQ | X |
CAPS: Clinical Administered interview for the diagnosis of Post-traumatic stress disorder; DES: Dissociative Experiences Scale; EPDS: Edinburgh Postnatal Depression Scale; IRMAG: Interview of Maternal Representations of Attachment during pregnancy; PPQ: Perinatal PTSD Questionnaire; STAI: State-Trait Anxiety Inventory.